Cargando…
A case of severe hypothyroidism due to lenalidomide
Lenalidomide, an immunomodulatory drug often used to treat multiple myeloma, can cause hypo‐ or hyperthyroidism. We present a patient being treated with lenalidomide for 2 years who developed severe hypothyroidism that was complicated by rhabdomyolysis and acute kidney injury. Thyroid function tests...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745361/ https://www.ncbi.nlm.nih.gov/pubmed/31534740 http://dx.doi.org/10.1002/ccr3.2362 |
_version_ | 1783451529660858368 |
---|---|
author | Blair, Rachel A. Leaf, Rebecca Karp Leaf, David E. |
author_facet | Blair, Rachel A. Leaf, Rebecca Karp Leaf, David E. |
author_sort | Blair, Rachel A. |
collection | PubMed |
description | Lenalidomide, an immunomodulatory drug often used to treat multiple myeloma, can cause hypo‐ or hyperthyroidism. We present a patient being treated with lenalidomide for 2 years who developed severe hypothyroidism that was complicated by rhabdomyolysis and acute kidney injury. Thyroid function tests should be serially monitored in patients taking lenalidomide. |
format | Online Article Text |
id | pubmed-6745361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67453612019-09-18 A case of severe hypothyroidism due to lenalidomide Blair, Rachel A. Leaf, Rebecca Karp Leaf, David E. Clin Case Rep Case Reports Lenalidomide, an immunomodulatory drug often used to treat multiple myeloma, can cause hypo‐ or hyperthyroidism. We present a patient being treated with lenalidomide for 2 years who developed severe hypothyroidism that was complicated by rhabdomyolysis and acute kidney injury. Thyroid function tests should be serially monitored in patients taking lenalidomide. John Wiley and Sons Inc. 2019-08-08 /pmc/articles/PMC6745361/ /pubmed/31534740 http://dx.doi.org/10.1002/ccr3.2362 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Blair, Rachel A. Leaf, Rebecca Karp Leaf, David E. A case of severe hypothyroidism due to lenalidomide |
title | A case of severe hypothyroidism due to lenalidomide |
title_full | A case of severe hypothyroidism due to lenalidomide |
title_fullStr | A case of severe hypothyroidism due to lenalidomide |
title_full_unstemmed | A case of severe hypothyroidism due to lenalidomide |
title_short | A case of severe hypothyroidism due to lenalidomide |
title_sort | case of severe hypothyroidism due to lenalidomide |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745361/ https://www.ncbi.nlm.nih.gov/pubmed/31534740 http://dx.doi.org/10.1002/ccr3.2362 |
work_keys_str_mv | AT blairrachela acaseofseverehypothyroidismduetolenalidomide AT leafrebeccakarp acaseofseverehypothyroidismduetolenalidomide AT leafdavide acaseofseverehypothyroidismduetolenalidomide AT blairrachela caseofseverehypothyroidismduetolenalidomide AT leafrebeccakarp caseofseverehypothyroidismduetolenalidomide AT leafdavide caseofseverehypothyroidismduetolenalidomide |